Hyun D. Kim
Corporate Officer/Principal chez EMBER THERAPEUTICS, INC.
Profil
Hyun D.
Kim is currently working as Vice President-Clinical Development at Ember Therapeutics, Inc. He previously worked as Director-Product Development at Anika Therapeutics, Inc., Director-Research & Development at Transport Pharmaceuticals, Inc., Director-Research & Development at Olympus Biotech Corp.
(United States), and Vice President-Clinical Development at Ember Therapeutics, Inc. Dr. Kim completed his undergraduate, graduate, and doctorate degrees from Brown University.
Postes actifs de Hyun D. Kim
| Sociétés | Poste | Début |
|---|---|---|
| EMBER THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Hyun D. Kim
| Sociétés | Poste | Fin |
|---|---|---|
| Olympus Biotech Corp. (United States) | Directeur Technique/Scientifique/R&D | - |
| ANIKA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Transport Pharmaceuticals, Inc.
 Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Directeur Technique/Scientifique/R&D | - |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formation de Hyun D. Kim
| Brown University | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| EMBER THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Transport Pharmaceuticals, Inc.
Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Health Technology |
| Olympus Biotech Corp. (United States) |